Probiotics for UTI prevention can help some women, but they do not treat an infection that has already started; antibiotics do that[1]. The strongest results come from specific Lactobacillus strains, mostly given vaginally, in women with repeat infections[2][3]. Pooled evidence is still mixed[4].
This guide covers which strains were tested and what happened, how oral and vaginal products compare, how probiotics stack up against cranberry and D-mannose, and the safety limits. For how urinary infections are diagnosed and treated, see our page on UTIs and the gut microbiome.
Get medical help promptly if you have urinary symptoms with fever, chills, pain in your lower back or side, or nausea and vomiting. These can signal a kidney infection, which needs a clinician and antibiotics, not a probiotic[1].
Can probiotics help stop urinary tract infections (UTIs)?
No probiotic has been shown to cure an active bladder infection. A clinician diagnoses it and prescribes an antibiotic, which is also the fastest way to clear it[1]. The open question is prevention: whether a daily or weekly probiotic means fewer repeat infections.
On that question, the major reviews and guidelines are cautious:
| Source | What it concluded about probiotics |
|---|---|
| Cochrane review, 9 trials, 735 people (2015) | No significant reduction vs placebo (RR 0.82, 95% CI 0.60 to 1.12); a benefit "cannot be ruled out"[4] |
| NICE guideline NG112 (UK, updated 2024) | Evidence is "inconclusive" for people with recurrent infections[5] |
| European Association of Urology (2025) | Weak recommendation for strains "of proven efficacy" to restore vaginal flora[6] |
| Overview of 27 systematic reviews (2026) | Stronger evidence is needed, as for D-mannose[7] |
| Network meta-analysis, 50 trials (2024) | Probiotics lowered infection risk vs placebo (RR 0.69, 95% CI 0.50 to 0.94)[8] |
The pattern behind these mixed verdicts is strain choice. Meta-analyses that pool every Lactobacillus product find no clear benefit, while analyses that drop strains already shown not to work find a positive effect[6]. Recurrent infection here means 2 or more in 6 months, or 3 or more in 12 months[5].
Children are a separate case. In children with normal urinary tracts, a 2021 meta-analysis found probiotics reduced repeat infections compared with placebo (RR 0.52, 95% CI 0.29 to 0.94), on low-quality evidence[9]. They were not better than antibiotic prophylaxis, but carried a lower risk of antibiotic resistance[9]. NICE advises specialist input for anyone under 16 with recurrent infections[5].
What causes 80% of UTIs, and where do probiotics fit?
About 80% of urinary infections are caused by uropathogenic Escherichia coli, which climbs the urethra into the bladder[10]. It can then invade bladder cells and form dormant reservoirs that may seed later recurrences[10].
The bacteria often start in the gut. The CDC notes that UTI-causing bacteria often come from the skin or rectum[1], and the gut is a known reservoir for them[11]. In a year-long study, women with recurrent infections had gut microbiomes with lower diversity and fewer butyrate-producing bacteria than women without them[11].
The vagina sits between the gut and the bladder. Women with recurrent infections often have more vaginal E. coli and fewer of the hydrogen peroxide-producing lactobacilli that normally dominate there[2]. Menopause and spermicides change vaginal bacteria and raise infection risk[1].
Probiotics for this use aim to restock those protective lactobacilli, such as Lactobacillus crispatus, and crowd out E. coli before it reaches the urethra. Our guide to vaginal pH balance explains how lactobacilli keep that environment acidic.
Which probiotic strains have been studied for UTIs?
Only certain probiotic strains have trial data for recurrent infections, and the European guideline names the ones with the highest efficacy[6]:
- Lactobacillus crispatus CTV-05
- L. rhamnosus GR-1
- L. reuteri B-54 and RC-14
- L. casei Shirota
A generic "women's probiotic" may contain none of them.
| Strain or product studied | How it was given | Who | Main result |
|---|---|---|---|
| L. crispatus CTV-05 (Lactin-V) | Vaginal, daily 5 days then weekly 10 weeks | 100 premenopausal women | Recurrence 15% vs 27% placebo; RR 0.5 (95% CI 0.2 to 1.2)[2] |
| Vaginal lactobacilli, with or without oral lactic acid bacteria and bifidobacteria | Vaginal, oral, or both, 4 months | 174 premenopausal women | UTI by 4 months: 40.9% vaginal, 31.8% both, 61.3% oral, 70.4% placebo[3] |
| L. rhamnosus GR-1 + L. reuteri RC-14 | Oral, twice daily, 12 months | 252 postmenopausal women | 3.3 UTIs each year vs 2.9 on an antibiotic; not proven as good, but no rise in resistance[12] |
| Two Lactobacillus strains + cranberry extract | Oral, twice daily, 26 weeks | 81 premenopausal women | Recurrence 9.1% vs 33.3% placebo[13] |
| GR-1 + RC-14, or LGG + Bifidobacterium BB-12 | Oral, 6 months | 207 people with spinal cord injury | No effect on infections[14] |
L. crispatus CTV-05 (vaginal)
In the Lactin-V trial, women first finished antibiotics for an acute infection, then used the suppository[2]. The headline difference (15% vs 27%) was not statistically significant. Women who kept high vaginal levels of L. crispatus throughout follow-up had a far lower risk (RR 0.07)[2].
A 2026 systematic review still rated this the most precise estimate in the field[15]. Lactin-V is not a product you can buy: its developer lists it as under development for bacterial vaginosis and preterm birth[16].
GR-1 and RC-14 (oral)
These two oral strains are on the European guideline's list[6]: one is L. rhamnosus, the other a strain of L. reuteri. In 64 healthy women, 60 days of the capsules raised vaginal lactobacilli and cut vaginal coliform bacteria compared with placebo[17].
In a long-term, head-to-head trial (12 months) against a daily antibiotic in postmenopausal women, they did not meet the test for being as effective: 79.1% on the probiotic had at least one infection, versus 69.3% on the antibiotic[12]. After one month on the antibiotic, though, 80% to 95% of the women's E. coli was resistant to it, up from 20% to 40%; resistance did not rise on the probiotic[12].
Strains that did not reach the vagina or did not help
Strain matters. When 42 postmenopausal women ate yogurt with L. rhamnosus GG for a month, it settled in the gut of 78.6% but the vagina of only 9.5%, and the authors advised against it for urinary infections[18]. In people with spinal cord injury and neurogenic bladder, neither GR-1/RC-14 nor LGG with BB-12 lowered infections[14].
Oral or vaginal probiotics: which works better?
Vaginal delivery has the stronger evidence. In the 2024 four-arm trial, oral probiotics alone did not significantly beat placebo, while vaginal lactobacilli, alone or combined with oral, significantly cut recurrences[3]:
- Mean infections by 4 months: 2.1 placebo, 1.63 oral, 1.06 vaginal, 1.07 combined.
- Days to first infection: 69 placebo, 72 oral, 124 vaginal, 142 combined.
A 2026 review of four trials (616 women) found the intravaginal route showed the most consistent benefit, linked to how well the bacteria recolonised the vagina[15]. A 2023 review of vaginal suppositories was more guarded: they appear safe, but whether they reduce recurrences "remains inconclusive", and the right dose and duration are unknown[19]. Oral strains can work only if they reach the vagina, which GR-1 and RC-14 did in one trial and LGG largely did not in another[17][18].
What can you take daily to prevent UTIs besides probiotics?
Probiotics are one of several non-antibiotic options, and not the best supported[7]. Here is how the main options compare:
| Option | Evidence for preventing repeat infections | Notes |
|---|---|---|
| Cranberry products | Cochrane: RR 0.74 (95% CI 0.55 to 0.99) in women with recurrent infections[20] | Beat probiotics head to head in 3 small trials (RR 0.39)[20]. See cranberry juice for UTIs |
| D-mannose | No significant benefit in the largest placebo-controlled trial[21] | See D-mannose for UTIs |
| Probiotics | RR 0.69 in one network meta-analysis[8]; no clear effect in Cochrane[4] | Vaginal strains look strongest[15] |
| Vaginal estrogen (after menopause) | Strong recommendation in European guidance[6] | NICE lists it before antibiotic prophylaxis[5] |
| Methenamine hippurate | NICE option instead of daily antibiotics[5] | Considered when simpler steps have not worked[5] |
The 2026 overview of 27 systematic reviews found support for cranberry, methenamine hippurate and vaginal estrogen after menopause, and said probiotics and D-mannose need stronger evidence[7]. Increased fluid intake helped women who drank little[7]. The CDC's everyday steps still apply: urinate after sex, stay hydrated, shower rather than bathe, and limit douches and sprays[1].
Does D-mannose work?
The best trial so far says no for women in primary care. In the largest placebo-controlled trial, 598 women in UK primary care took 2 g a day for 6 months: 51.0% still had another suspected infection, versus 55.7% on placebo, a difference that was not significant[21]. A 2024 network meta-analysis of 50 trials covering 14 options estimated a large effect for D-mannose (RR 0.34)[8], which that large trial did not reproduce.
Can yogurt or fermented foods help prevent UTIs?
Possibly, but the evidence is weak. In a Finnish case-control study, women who ate fermented milk products with probiotic bacteria 3 or more times a week had lower odds of infection than those eating them less than once a week (OR 0.21)[22]. That links diet with risk; it does not prove yogurt prevents infections.
Most yogurt cultures are not the strains tested for this purpose, and one common strain, LGG, rarely reached the vagina[18]. Our probiotic foods guide lists what fermented foods actually contain.
How to choose a probiotic for UTI prevention
If you and your clinician decide to try one, base the choice on what was actually tested[6]:
Look for the strain code, not just the species. Benefits are strain-specific, so one Lactobacillus doing something does not mean another will[23]. Names like GR-1, RC-14 or CTV-05 are what the trials tested[6].
Consider the route. Vaginal products have more consistent data than oral capsules alone[15].
Give it trial-length time. Studies ran from 10 weeks to 12 months[2][12]; no one knows the ideal duration[6].
Treat any active infection first. In the Lactin-V trial, women were treated for their infection before starting the probiotic[2].
Know that supplements are not pre-approved. Many probiotics are sold as supplements without FDA approval, and some products have contained organisms not on the label[23].
If you are on antibiotics now, our guide to probiotics while taking antibiotics covers timing. Our women's vaginal and urinary health protocol puts probiotic, cranberry and D-mannose steps into one plan, and probiotics for BV and yeast infections covers the overlapping vaginal conditions.
Are probiotics safe, and which people should not take them?
Side effects reported in these trials were mostly mild, though few studies have looked at probiotic safety in detail[23]. The Cochrane review listed diarrhoea, nausea, vomiting, constipation and vaginal symptoms as the most common[4]. With the Lactin-V suppository, 56% of users and 50% on placebo reported effects such as discharge, itching or mild abdominal discomfort[2]. No serious adverse events were reported in the 2024 trial[3].
The people who should not take probiotics without medical advice are those with serious illness or a weakened immune system, and premature infants, in whom the FDA has warned of severe and fatal infections[23]. More is not known to be better: the European guideline says the evidence cannot yet define the right dose[6]. For general side effects, see probiotic side effects.
When to see a doctor
Probiotics are not a reason to delay care[23]. See a healthcare professional if you:
- have any urinary symptoms, such as burning, urgency, frequent urination, blood in the urine or lower abdominal pressure[1];
- develop fever, chills, back or side pain, nausea or vomiting[1];
- are pregnant, male, under 16, or have repeat upper urinary infections, groups NICE says need specialist input[5];
- have symptoms that do not improve on antibiotics or get worse[1];
- have symptoms that could be a sexually transmitted infection, which can look similar[1].
A child under 3 months with a temperature of 100.4 °F (38 °C) or higher needs care right away[1].
This article is for general educational purposes and is not medical advice. Probiotic products differ in strains, dose and quality, and many are sold as supplements without FDA approval. Talk to a qualified healthcare professional before using probiotics to prevent urinary infections, particularly if you are pregnant, immunocompromised, taking prescription medication, or managing a diagnosed condition.
Frequently Asked Questions
Can I take probiotics with antibiotics for a UTI?
Probiotics are not a substitute for the antibiotic, which is what treats the infection. In the best-known vaginal probiotic trial, women finished their antibiotic for the acute infection first and started the Lactobacillus crispatus suppository afterwards. If you want an oral probiotic during the course for gut side effects, see our guide to taking probiotics while on antibiotics for timing and spacing, and tell your prescriber what you are taking.
Can probiotics cause UTI-like symptoms?
We found no trial showing that probiotics cause urinary infections. In the Lactin-V trial, side effects were reported by 56% of women using the vaginal probiotic and 50% using placebo, mostly vaginal discharge, itching or mild abdominal discomfort. A Cochrane review listed diarrhoea, nausea, vomiting, constipation and vaginal symptoms as the most common complaints. Burning when you urinate, urgency or blood in your urine point to an infection that needs testing, not to the probiotic.
Do probiotics help prevent UTIs in men?
There is very little evidence. The recurrent-infection trials we read enrolled women, except one Australian trial in 207 people with spinal cord injury and neurogenic bladder, including men, found no effect of either probiotic combination tested. NICE advises that men aged 16 and over with recurrent infections are referred or seen with specialist advice, because repeat infections in men need investigating.
Why do older women get more UTIs?
Menopause changes the bacteria living in the vagina, and the CDC lists those changes as a risk factor for urinary infections. Researchers describe a loss of vaginal lactobacilli in postmenopausal women, linked to falling estrogen, as an important factor in bacteria reaching the urine. This is why vaginal estrogen, rather than a probiotic, is the step NICE and the European Association of Urology recommend for postmenopausal women with repeat infections.
Can probiotics help with both UTIs and yeast infections?
Some of the same Lactobacillus strains have been studied for both. In 64 healthy women, oral L. rhamnosus GR-1 and L. fermentum RC-14 (now called L. reuteri RC-14) increased vaginal lactobacilli and reduced yeast and coliform bacteria in the vagina. That is a change in vaginal flora, not proof of fewer infections. Our guide to probiotics for BV and yeast infections covers the trials for those conditions.
Can probiotics clear up a UTI quickly?
No. No probiotic has been shown to clear an active infection, and the CDC states that antibiotics treat UTIs; a healthcare professional decides which one you need. Drinking plenty of fluids can help you feel better while the antibiotic works. Contact a clinician if symptoms do not improve after starting antibiotics or get worse. Probiotics were studied for preventing the next infection, not for treating the current one.
What can mimic a UTI?
The CDC notes that symptoms of a sexually transmitted infection can look like a UTI, so it is worth asking whether you should be tested. In men, a clinician may need to check the prostate for inflammation or infection. Bacteria can also be present in urine without causing illness, called asymptomatic bacteriuria, which usually does not need antibiotics. A urine test is the way to tell these apart.
Can you take too many probiotics?
There is no evidence that a bigger dose prevents more infections. The European Association of Urology says the data are too limited to define the right dose, route or duration. The trials used set amounts, such as capsules with 1 billion colony-forming units of GR-1 and RC-14 twice a day, or a vaginal suppository once a week after a 5-day start. People with serious illness or a weakened immune system face a higher risk of harm from probiotics and should ask a clinician first.
References
- Centers for Disease Control and Prevention. Urinary Tract Infection Basics. CDC. 2026. Available at: https://www.cdc.gov/uti/about/index.html ↩
- Stapleton AE, Au-Yeung M, Hooton TM, et al.. Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clinical Infectious Diseases. 2011;52(10):1212-1217. doi:10.1093/cid/cir183 ↩
- Gupta V, Mastromarino P, Garg R. Effectiveness of Prophylactic Oral and/or Vaginal Probiotic Supplementation in the Prevention of Recurrent Urinary Tract Infections: A Randomized, Double-Blind, Placebo-Controlled Trial. Clinical Infectious Diseases. 2024;78(5):1154-1161. doi:10.1093/cid/ciad766 ↩
- Schwenger EM, Tejani AM, Loewen PS. Probiotics for preventing urinary tract infections in adults and children. Cochrane Database of Systematic Reviews. 2015;2015(12):CD008772. doi:10.1002/14651858.CD008772.pub2 ↩
- National Institute for Health and Care Excellence. Urinary tract infection (recurrent): antimicrobial prescribing. NICE guideline NG112 (last updated December 2024). NICE. 2024. Available at: https://www.nice.org.uk/guidance/ng112/chapter/recommendations ↩
- European Association of Urology. EAU Guidelines on Urological Infections: recurrent cystitis. European Association of Urology. 2025. Available at: https://uroweb.org/guidelines/urological-infections/chapter/the-guideline ↩
- Santer M, Miller S, Fraser S, et al.. Non-antibiotic interventions to prevent recurrent urinary tract infections in women: overview of systematic reviews of randomised controlled trials. British Journal of General Practice. 2026. doi:10.3399/BJGP.2026.0055 ↩
- Han Z, Yi X, Li J, Liao D, Ai J. Nonantibiotic prophylaxis for urinary tract infections: a network meta-analysis of randomized controlled trials. Infection. 2024;53(2):535-546. doi:10.1007/s15010-024-02357-z ↩
- Meena J, Thomas CC, Kumar J, Raut S, Hari P. Non-antibiotic interventions for prevention of urinary tract infections in children: a systematic review and meta-analysis of randomized controlled trials. European Journal of Pediatrics. 2021;180(12):3535-3545. doi:10.1007/s00431-021-04091-2 ↩
- Lupo F, Ingersoll MA, Pineda MA. The glycobiology of uropathogenic E. coli infection: the sweet and bitter role of sugars in urinary tract immunity. Immunology. 2021;164(1):3-14. doi:10.1111/imm.13330 ↩
- Worby CJ, Schreiber HL, Straub TJ, et al.. Longitudinal multi-omics analyses link gut microbiome dysbiosis with recurrent urinary tract infections in women. Nature Microbiology. 2022;7(5):630-639. doi:10.1038/s41564-022-01107-x ↩
- Beerepoot MA, ter Riet G, Nys S, et al.. Lactobacilli vs Antibiotics to Prevent Urinary Tract Infections. Archives of Internal Medicine. 2012;172(9):704-712. doi:10.1001/archinternmed.2012.777 ↩
- Koradia P, Kapadia S, Trivedi Y, et al.. Probiotic and cranberry supplementation for preventing recurrent uncomplicated urinary tract infections in premenopausal women: a controlled pilot study. Expert Review of Anti-infective Therapy. 2019;17(9):733-740. doi:10.1080/14787210.2019.1664287 ↩
- Toh SL, Lee BB, Ryan S, et al.. Probiotics [LGG-BB12 or RC14-GR1] versus placebo as prophylaxis for urinary tract infection in persons with spinal cord injury [ProSCIUTTU]: a randomised controlled trial. Spinal Cord. 2019;57(7):550-561. doi:10.1038/s41393-019-0251-y ↩
- Yauri-Idelfonso M, Picón-Rafaelo C, Rosales-Goñe P, et al.. Probiotic prophylaxis in adult women with recurrent uncomplicated urinary tract infections: A systematic review of randomized controlled trials. Journal of Global Antimicrobial Resistance. 2026;50:122-129. doi:10.1016/j.jgar.2026.06.006 ↩
- Osel Inc.. Clinical Pipeline: LACTIN-V. Osel Inc.. 2026. Available at: https://oselinc.com/clinical-pipeline/ ↩
- Reid G, Charbonneau D, Erb J, et al.. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunology and Medical Microbiology. 2003;35(2):131-134. doi:10.1016/S0928-8244(02)00465-0 ↩
- Colodner R, Edelstein H, Chazan B, Raz R. Vaginal colonization by orally administered Lactobacillus rhamnosus GG. Israel Medical Association Journal. 2003;5(11):767-769. Available at: https://pubmed.ncbi.nlm.nih.gov/14650098/ ↩
- Shoureshi PS, Niino C, Eilber KS. Can vaginal lactobacillus suppositories help reduce urinary tract infections?. International Urogynecology Journal. 2023;34(11):2713-2718. doi:10.1007/s00192-023-05568-4 ↩
- Williams G, Stothart CI, Hahn D, et al.. Cranberries for preventing urinary tract infections. Cochrane Database of Systematic Reviews. 2023;2023(11):CD001321. doi:10.1002/14651858.CD001321.pub7 ↩
- Hayward G, Mort S, Hay AD, et al.. d-Mannose for Prevention of Recurrent Urinary Tract Infection Among Women: A Randomized Clinical Trial. JAMA Internal Medicine. 2024;184(6):619-628. doi:10.1001/jamainternmed.2024.0264 ↩
- Kontiokari T, Laitinen J, Järvi L, et al.. Dietary factors protecting women from urinary tract infection. American Journal of Clinical Nutrition. 2003;77(3):600-604. doi:10.1093/ajcn/77.3.600 ↩
- National Center for Complementary and Integrative Health. Probiotics: Usefulness and Safety. NCCIH. 2019. Available at: https://www.nccih.nih.gov/health/probiotics-usefulness-and-safety ↩